Partner Article

New retailers for pain relief products - ActiPatch

BioElectronics Corporation, the maker of advanced consumer pain management medical devices, today announced that it has received an initial order for its ActiPatch® Musculoskeletal Pain Relief products from Superdrug pharmacies. Superdrug is a subsidiary of the A.S. Watson Group, the world’s largest international health and beauty retailer with 12,000 stores. Superdrug will promote BioElectronics’ 7-Day Trial Device, Try & Tell Marketing Campaign online and stock ActiPatch in 186 stores.

“Superdrug will promote BioElectronics 7-Day Trial Device, to create product demand on their web site,” said Ben Fichter, Marketing Director, BioElectronics Corporation. “We are looking forward to collaborating with this innovative retailer to extend our successful marketing program into the retail environment.”

ActiPatch® products will also be stocked in 1,077 Lloyd’s pharmacies, the second largest chain in the UK, and Gordons Chemist (Northern Ireland).

“The product placement and initial orders to stock these pharmacies are a substantial gain, but even more important long-term is the opportunity to work with the pharmacist to provide one-to-one consultation for chronic pain sufferers on the unique benefits and safety of ActiPatch” said Ben Fichter, Marketing Manager. “This is a great way to help patients discover how drug-free ActiPatch Therapy can help them manage their pain and restore daily activities while minimizing drug dependency.”

The BioElectronics ActiPatch® range retails at £19.99 per product and includes:

ActiPatch® 720 hour Knee Pain Relief ActiPatch® 720 hour Back Pain Relief ActiPatch® 720 hour Muscle and Joint Pain Relief

For more information about BioElectronics ActiPatch®, please visit www.tryactipatch.co.uk

Stockists: Boots, www.boots.com, Superdrug, www.superdrug.com, Lloyds Pharmacy, Gordons Chemists (Northern Ireland) and independent pharmacies.

This was posted in Bdaily's Members' News section by Liz Crosley .